3-iodobenzylguanidine has been researched along with phenformin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsiao, R; Ikegaki, N; Limpar, MM; Lomahan, S; Maloney, NJ; Tang, XX; Tran, TA; Wang, SS | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and phenformin
| Article | Year |
|---|---|
Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.
Topics: 3-Iodobenzylguanidine; Acetylation; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Metformin; Mitochondria; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Phenformin; Proto-Oncogene Proteins c-myc; Up-Regulation | 2014 |